4//SEC Filing
Thomas Dolca 4
Accession 0001104659-25-049419
CIK 0001564824other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:06 PM ET
Size
7.6 KB
Accession
0001104659-25-049419
Insider Transaction Report
Form 4
Allakos Inc.ALLK
Thomas Dolca
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-05-15−154,786→ 0 totalExercise: $5.55Exp: 2033-08-01→ Common Stock (154,786 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-05-15−41,000→ 0 totalExercise: $1.42Exp: 2034-05-24→ Common Stock (41,000 underlying)
Footnotes (1)
- [F1]This option was cancelled without consideration pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc.
Documents
Issuer
Allakos Inc.
CIK 0001564824
Entity typeother
Related Parties
1- filerCIK 0001768239
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:06 PM ET
- Size
- 7.6 KB